In MCF-7 breast cancer cells, which retain functional BRCA1, Marzec et al. demonstrated that overexpression of BARD1ω significantly reduced apoptosis following treatment with cisplatin when compared to cells expressing wild-type FL-BARD1. This evidence concerns the gene BARD1 and breast carcinoma.